Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa

Archives of General Psychiatry

Volumn 55, Issue 10, 1998, Pages 927-935

  Kaye, Walter H ^a   Greeno, Catherine G ^a   Moss, Howard ^a   Fernstrom, John ^a   Fernstrom, Madelyn ^a   Lilenfeld, Lisa R ^a   Weltzin, Theodore E ^a   Mann, J John ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 3 HYDROXYBUTYRIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; ESTRADIOL; HOMOVANILLIC ACID; HYDROCORTISONE; NORADRENALIN; PROGESTERONE; PROLACTIN; SEROTONIN; TRYPTOPHAN;

ADULT; AFFECTIVE NEUROSIS; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BINGE EATING DISORDER; BIRTH CONTROL; BODY WEIGHT; BULIMIA; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MENSTRUAL CYCLE; OBSESSION; PATHOGENESIS; PSYCHIATRIC DIAGNOSIS; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADULT; AFFECT; BODY WEIGHT; BRAIN CHEMISTRY; BULIMIA; FEEDING BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HOMOVANILLIC ACID; HUMANS; HYDROCORTISONE; HYDROXYINDOLEACETIC ACID; MENTAL DISORDERS; METHOXYHYDROXYPHENYLGLYCOL; PIPERAZINES; PLACEBOS; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN;

EID: 0031669067     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.10.927     Document Type: Article

References (76)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
2. Gwirtsman HE, Roy-Burne P, Yager J. Neuroendocrine abnormalities in bulimia. Am J Psychiatry. 1983;140:559.
3. Lilenfeld LR, Kaye WH, Greeno CG, Plotnicov KH, Pollice CP, Rao R, Strober M, Bulik CM, Nagy L. A controlled family study of anorexia and bulimia nervosa: psychiatric and effects of proband comorbidity. Arch Gen Psychiatry. 1998;55: 603-610.
4. Morley JE, Blundell JE. The neurobiological basis of eating disorders: some formulations. Biol Psychiatry. 1988;23:53-78.
5. Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Arch Gen Psychiatry. 1992;49:852-861.
6. Levitan RD, Kaplan AS, Russell JT, Levitt AJ, Brown GM. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine (m-CPP) in bulimia nervosa. Arch Gen Psychiatry. 1997;54:521-527.
7. Goldbloom DS, Garfinkel PE, Katz R, Brown G. The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa. Psychosom Med. 1990;52: 225-226.
8. Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM. Decreased serotonin function in bulimia nervosa. Arch Gen Psychiatry. 1997;54: 529-534.
9. Weltzin TE, Fernstrom MH, Fernstrom JD, Neurberger SK, Kaye WH. Acute tryptophan depletion in bulimia nervosa: increased food intake and irritability. Am J Psychiatry. 1995;152:1668-1671.
10. Kaye WH, Ballenger JC, Lydiard RB, Stuart GW, Laraia MT, O'Neil P, Fossey MD, Stevens V, Lesser S, Hsu G. CSF monoamines levels in normal-weight bulimia: evidence for altered noradrenergic activity. Am J Psychiatry. 1990;147:225-229.
11. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge epidsodes. Arch Gen Psychiatry. 1992;49:132-138.
12. Pirke KM. Central and peripheral noradrenalin regulation in eating disorders. Psychiatry Res. 1996;62:43-49.
13. Walsh BT. Psychopharmacologic treatment of bulimia nervosa. J Clin Psychiatry. 1991;52(suppl):34-38.
14. Mitchell JE, Raymond N, Specker S. A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. Int J Eat Disord. 1993;14:229-147.
15. Caccia S, Ballabio M, Samanin R, Zanini G, Garattini S. m-Chlorophenylpiperazine, a central 5-hydoxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol. 1981;33:477-478.
16. Metropolitan Life Insurance Company. New weight standards for men and women. Stat Bull Metrop Insur Co. 1959;40:1-11.
17. Endicott J, Spitzer RL. A diagnostic interview. Arch Gen Psychiatry. 1978;35: 837-844.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
20. Spielberger CD, Gorsuch RL, Lushene RE. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1970.
21. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS), I: development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
22. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS), II. validity. Arch Gen Psychiatry. 1989;46:1012-1016.
23. Sunday SR, Halmi KA, Einhorn A. The Yale-Brown-Cornell Eating Disorders Scale: a new scale to assess eating disorder symptomatology. Int J Eat Disord. 1995; 18:237-245.
24. Garner DM, Olmstead MP, Polivy J. The Eating Disorder Inventory: a measure of cognitive-behavioral dimensions of anorexia nervosa and bulimia. In: Darby PL, Garfinkel PE, Garner DM, Coscina DV, eds. Anorexia Nervosa: Recent Developments in Research. New York, NY: Alan R Liss Inc; 1983;173-184.
25. Frost RO, Marten P, Lahart C, Rosenblate R. The dimensions of perfectionism. Cogn Ther Res. 1990;14:449-468.
26. Goodwin GM, Fairburn CG, Cowen PJ. The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Arch Gen Psychiatry. 1987;44:952-957.
27. Fernstrom MH, Fernstrom JD. Diet, brain neurotransmitters, and food selection. In: Walsh BT, ed. Eating Behavior in Eating Disorders. New York, NY: American Psychiatric Press; 1988:37-50.
28. Agren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ. Interacting neurotransmitter systems: a nonexperimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res. 1986;20:175-193.
29. Brewerton TD, Berettini WH, Nurnberger JI, Linnoila M. Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls: findings with 5HIAA and HVA. Psychiatr Res. 1988;23:257-265.
30. Munaro NI. The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity. Neuroendocrinology. 1978;26:270-276.
31. Overall JH, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962; 10:799-812.
32. Murphy DL, Pickar D, Alterman IS. Methods for the quantitative assessment of depressive and manic behavior. In: Burdock EI, Sudilovsky A, Gershon S, eds. The Behavior of Psychiatric Patients. New York, NY: Marcel Dekker Inc; 1982: 355-391.
33. Scheinin M, Chang WH, Kirk KL, Linnoila M. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. Anal Biochem. 1983;131:246-253.
34. Williamson DH, Mellanby J, Krebs HA. Enzymatic determination of D(-) hydroxybutyric acid and acetoacetic acid in blood. Biochem J. 1962;82:90-96.
35. Denckla WD, Dewey HK. Determination of tryptophan in plasma, liver and urine. J Lab Clin Med. 1967;69:160-169.
36. Fernstrom JD, Fernstrom MH, Grubb PE. Twenty-four-hour variations in rat blood and brain levels of the aromatic and branched-chain amino acids: chronic effects of dietary protein content. Metabolism. 1987;36:643-650.
37. Kao M, Voina S, Nichols A, Horton R. Parallel radioimmunoassay for plasma cortisol and 11-deoxycortisol. Clin Chem. 1975;21:1644-1647.
38. Sinha YN, Selby FW, Lewis UJ, Vanderlaan WP. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973;36:509-516.
39. Suckow RF, Cooper TB. High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. J Chromatogr A. 1990;528: 228-234.
40. Dixon J. BMDP Statistical Software. Berkeley, Calif: University of California Press; 1985.
41. Fernstrom JD. Aromatic amino acids and monoamine synthesis in the central nervous system: influence in diet. J Nutr Biochem. 1990;1:508-517.
42. Keel PK, Mitchell JE. Outcome in bulimia nervosa. Am J Psychiatry. 1997;154: 313-321.
43. Johnson-Sabine E, Reiss D, Dayson D. Bulimia nervosa: a 5-year follow-up study. Psychol Med. 1992;22:951-959.
44. Fallon BA, Walsh BT, Sadik C, Saoud JB, Lukasik V. Outcome and clinical course in inpatient bulimic women: a 2-to 9-year follow-up study. J Clin Psychiatry. 1991;52:272-278.
45. Norring CEA, Sohlberg SS. Outcome, recovery, relapse and mortality across six years in patients with clinical eating disorders. Acta Psychiatr Scand. 1993;87: 437-444.
46. Keller MB, Herzog DB, Lavori PW, Bradburn IS, Mahoney EM. The naturalistic history of bulimia nervosa: extraordinarily high rates of chronicity, relapse, recurrence, and psychosocial morbidity. Int J Eat Disord. 1992;12:1-9.
47. Collings S, King M. Ten-year follow-up of 50 patients with bulimia nervosa. Br J Psychiatry. 1994;164:80-87.
48. Strober M. Family-genetic studies of eating disorders. J Clin Psychiatry. 1991; 52:9-12.
49. Kendler SK, MacLean C, Neale M, Kessler R, Heath A, Eaves L. The genetic epidemiology of bulimia nervosa. Am J Psychiatry. 1991;148:1627-1637.
50. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves L. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Arch Gen Psychiatry. 1995;52:374-383.
51. Brewerton TD. Toward a unified theory of serotonin dysregulation in eating ana related disorders. Psychoneuroendocrinology. 1995;20:561-590.
52. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain serotonin function in women. J Psychol Med. 1990;20:785-791.
53. Schweiger V, Warnoff M, Pahl J, Pirke K. Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose and insulin plasma levels of anorectic patients. Metabolism. 1986;35:938-943.
54. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH. CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subiects normalize after weight gain. Biol Psychiatry. 1988;23:102-105.
55. Fink G, Summner BEH. Oestrogen and mental state. Nature. 1996;383:306.
56. McQueen JK, Wilson H, Dow RC, Fink GJ. Oestradiol-17 beta increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J Physiol (Lond). 1996;495:114.
57. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Leibowitz MR. Serotonergic function in obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:21-28.
58. Wolfe BE, Jimerson DC, Metzger ED, Levine JM. Serotonergic challenge response in women with a history of bulimia nervosa. Biol Psychiatry. 1994;35: 736-737.
59. Ishizuka B, Quigley ME, Yen SSC. Pituitary hormone release in response to food ingestion: evidence for neuroendocrine signals from gut to brain. J Clin Endocrinol Metab. 1983;57:1111.
60. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med. 1990;20:785-791.
61. O'Keane V, O'Hanion M, Webb M, Dinan T. D-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for oestrogen-induced alteration. Clin Endocrinol. 1991;34:289-292.
62. Johanson B, Roos BE. 5-Hydroxyindoleacetic acid and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome. Life Sci 1967;6:1449-1454.
63. Stanely M, Träskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolite simultaneously attained from human CSF and brain. Life Sci. 1985; 1279-1286.
64. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54:337-343.
65. Tuinier S, Verhoeven WMA, van Praag HM. Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. Int Clin Psychopharmacol. 1995;10:147-156.
66. Kaye WH, Gwirtsman HE, George DT, Ebert MH. Altered serotonin activity in anorexia nervosa after long-term weight restoration: does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry. 1991;48:556-562.
67. Srinivasagam NM, Plotnicov KH, Greeno C, Weltzin TE, Rao R, Kaye WH. Persistent perfectionism, symmetry, and exactness in anorexia nervosa after long-term recovery. Am J Psychiatry. 1995;11:1630-1634.
68. Bastiani AM, Rao R, Weltzin T, Kaye WH. Perfectionism in anorexia nervosa. Int J Eat Disord. 1995;17:147-152.
69. Pollice C, Kaye WH, Greeno CG, Weltzin TE. Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord. 1997; 21:367-376.
70. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-90.
71. Lilenfeld LR, Strober M, Kaye WH. Genetics and family studies of anorexia nervosa and bulimia nervosa. In: Kaye WH, Jimerson DC, eds. Eating Disorders: Balliére's Clinical Psychiatry. London, England: Balliére's Tindall Inc; 1997:177-197.
72. Kaye WH, Nagata T, Weltzin TE, Hsu LKG, Sokol MS, McConaha C, Plotnicov KH, Weise J, Deep D. Successful outcome of restricting-type anorexia nervosa after the double-blind placebo-controlled administration of fluoxetine. Am J Psychiatry. In press.
73. Brewerton TD, Hand LD, Bishop ER. The Tridimensional Personality Questionnaire in eating disorder patients. Int J Eat Disord. 1993;14:213-218.
74. Kleifield EI, Sunday S, Hurt S, Halmi KA. The Tridimensional Personality Questionnaire: an exploration of personality traits in eating disorders. J Psychiatr Res. 1993;28:413-423.
75. Bulik CM, Sullivan SA, Weltzin TE, Kaye WH. Temperament in eating disorders. Int J Eat Disord. 1995;17:251-261.
76. O'Dwyer AM, Lucey JV, Russell GFM. Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge. Psychol Med. 1996;26:353-359.